TRF1 averts chromatin remodelling, recombination and replication dependent-Break Induced Replication at mouse telomeres

  1. Rosa Maria Porreca
  2. Emilia Herrera-Moyano
  3. Eleni Skourti
  4. Pui Pik Law
  5. Roser Gonzalez Franco
  6. Alex Montoya
  7. Peter Faull
  8. Holger Kramer
  9. Jean-Baptiste Vannier  Is a corresponding author
  1. MRC London Institute of Medical Sciences, United Kingdom
  2. The Francis Crick Institute, United Kingdom

Abstract

Telomeres are a significant challenge to DNA replication and are prone to replication stress and telomere fragility. The shelterin component TRF1 facilitates telomere replication but the molecular mechanism remains uncertain. By interrogating the proteomic composition of telomeres, we show that mouse telomeres lacking TRF1 undergo protein composition reorganisation associated with the recruitment of DNA damage response and chromatin remodellers. Surprisingly, mTRF1 suppresses the accumulation of promyelocytic leukemia (PML) protein, BRCA1 and the SMC5/6 complex at telomeres, which is associated with increased Homologous Recombination (HR) and TERRA transcription. We uncovered a previously unappreciated role for mTRF1 in the suppression of telomere recombination, dependent on SMC5 and also POLD3 dependent Break Induced Replication at telomeres. We propose that TRF1 facilitates S-phase telomeric DNA synthesis to prevent illegitimate mitotic DNA recombination and chromatin rearrangement.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.Proteomic data have been made available at PRIDE, under the accession code PXD017022.

The following data sets were generated

Article and author information

Author details

  1. Rosa Maria Porreca

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Emilia Herrera-Moyano

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Eleni Skourti

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Pui Pik Law

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8924-0462
  5. Roser Gonzalez Franco

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Alex Montoya

    Biological Mass Spectrometry and Proteomics Facility, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Peter Faull

    Proteomics Mass Spectrometry Science and Technology Platform, The Francis Crick Institute, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8491-8086
  8. Holger Kramer

    Biological Mass Spectrometry and Proteomics Facility, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Jean-Baptiste Vannier

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    For correspondence
    j.vannier@lms.mrc.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4471-1854

Funding

European Commission (637798 MetDNASecStr)

  • Pui Pik Law

Medical Research Council (MRC Career Development Award)

  • Emilia Herrera-Moyano
  • Pui Pik Law
  • Roser Gonzalez Franco
  • Alex Montoya
  • Holger Kramer
  • Jean-Baptiste Vannier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Raymund Wellinger, Université de Sherbrooke, Canada

Publication history

  1. Received: July 1, 2019
  2. Accepted: January 11, 2020
  3. Accepted Manuscript published: January 14, 2020 (version 1)
  4. Version of Record published: January 28, 2020 (version 2)
  5. Version of Record updated: February 7, 2020 (version 3)
  6. Version of Record updated: February 10, 2020 (version 4)

Copyright

© 2020, Porreca et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,852
    Page views
  • 507
    Downloads
  • 14
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rosa Maria Porreca
  2. Emilia Herrera-Moyano
  3. Eleni Skourti
  4. Pui Pik Law
  5. Roser Gonzalez Franco
  6. Alex Montoya
  7. Peter Faull
  8. Holger Kramer
  9. Jean-Baptiste Vannier
(2020)
TRF1 averts chromatin remodelling, recombination and replication dependent-Break Induced Replication at mouse telomeres
eLife 9:e49817.
https://doi.org/10.7554/eLife.49817

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Sumedha Dahal, Humaira Siddiqua ... Sathees C Raghavan
    Research Article Updated

    Having its genome makes the mitochondrion a unique and semiautonomous organelle within cells. Mammalian mitochondrial DNA (mtDNA) is a double-stranded closed circular molecule of about 16 kb coding for 37 genes. Mutations, including deletions in the mitochondrial genome, can culminate in different human diseases. Mapping the deletion junctions suggests that the breakpoints are generally seen at hotspots. ‘9 bp deletion’ (8271–8281), seen in the intergenic region of cytochrome c oxidase II/tRNALys, is the most common mitochondrial deletion. While it is associated with several diseases like myopathy, dystonia, and hepatocellular carcinoma, it has also been used as an evolutionary marker. However, the mechanism responsible for its fragility is unclear. In the current study, we show that Endonuclease G, a mitochondrial nuclease responsible for nonspecific cleavage of nuclear DNA during apoptosis, can induce breaks at sequences associated with ‘9 bp deletion’ when it is present on a plasmid or in the mitochondrial genome. Through a series of in vitro and intracellular studies, we show that Endonuclease G binds to G-quadruplex structures formed at the hotspot and induces DNA breaks. Therefore, we uncover a new role for Endonuclease G in generating mtDNA deletions, which depends on the formation of G4 DNA within the mitochondrial genome. In summary, we identify a novel property of Endonuclease G, besides its role in apoptosis and the recently described ‘elimination of paternal mitochondria during fertilisation.

    1. Cell Biology
    Amanda E Brandon, Lewin Small ... Gregory J Cooney
    Research Article Updated

    Obesity is generally associated with insulin resistance in liver and muscle and increased risk of developing type 2 diabetes, however there is a population of obese people that remain insulin sensitive. Similarly, recent work suggests that mice fed high carbohydrate diets can become obese without apparent glucose intolerance. To investigate this phenomenon further, we fed mice either a high fat (Hi-F) or high starch (Hi-ST) diet and measured adiposity, glucose tolerance, insulin sensitivity, and tissue lipids compared to control mice fed a standard laboratory chow. Both Hi-ST and Hi-F mice accumulated a similar amount of fat and tissue triglyceride compared to chow-fed mice. However, while Hi-F diet mice developed glucose intolerance as well as liver and muscle insulin resistance (assessed via euglycaemic/hyperinsulinaemic clamp), obese Hi-ST mice maintained glucose tolerance and insulin action similar to lean, chow-fed controls. This preservation of insulin action despite obesity in Hi-ST mice was associated with differences in de novo lipogenesis and levels of C22:0 ceramide in liver and C18:0 ceramide in muscle. This indicates that dietary manipulation can influence insulin action independently of the level of adiposity and that the presence of specific ceramide species correlates with these differences.